Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model.
about
Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies.Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine.Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China.Cost-effectiveness analysis of routine 13-valent pneumococcal conjugate vaccinations in Chinese infants.A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in NPotential targets for next generation anti-microbial glycoconjugate vaccines.
P2860
Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Cost-effectiveness analysis of ...... vaccine using a Markov model.
@en
Cost-effectiveness analysis of ...... vaccine using a Markov model.
@nl
type
label
Cost-effectiveness analysis of ...... vaccine using a Markov model.
@en
Cost-effectiveness analysis of ...... vaccine using a Markov model.
@nl
prefLabel
Cost-effectiveness analysis of ...... vaccine using a Markov model.
@en
Cost-effectiveness analysis of ...... vaccine using a Markov model.
@nl
P2093
P2860
P1433
P1476
Cost-effectiveness analysis of ...... vaccine using a Markov model.
@en
P2093
Eleni Theodorou
Emmanuelle Delgleize
Nicolas Van de Velde
Oscar Leeuwenkamp
P2860
P304
P356
10.1136/BMJOPEN-2015-010776
P577
2016-11-30T00:00:00Z